Serina Therapeutics: Funding, Investors & Team (Sep 2026)
Serina Therapeutics is a private pharmaceutical company developing innovative treatments for cancer, inflammation, pain, and metabolic disorders by utilizing their special polymer technology. They have developed new drug options by combining polyoxazoline (POZ), a secure, water-soluble polymer, with various small molecules, proteins, peptides, and DNA. Attaching these substances to POZ polymers can create a distinct pharmacokinetic profile that differs from the original compound, potentially offering advantages in terms of effectiveness and safety.
Serina Therapeutics has raised $10.0M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Apr 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Serina Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Serina Therapeutics Funding Rounds
Serina Therapeutics raised $5.0M in an undisclosed round announced in Dec 2024.
4 months later, an undisclosed round of $5.0M was announced in Apr 2025.
Serina Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Serina Therapeutics Funding Compared to Other Biotechnology Startups
Serina Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Serina Therapeutics in Biotechnology and Huntsville
Companies Similar to Serina Therapeutics
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Serina Therapeutics Funding FAQs
What does Serina Therapeutics do?
Serina Therapeutics is a private pharmaceutical company developing innovative treatments for cancer, inflammation, pain, and metabolic disorders by utilizing their special polymer technology. They have developed new drug options by combining polyoxazoline (POZ), a secure, water-soluble polymer, with various small molecules, proteins, peptides, and DNA. Attaching these substances to POZ polymers can create a distinct pharmacokinetic profile that differs from the original compound, potentially offering advantages in terms of effectiveness and safety.
How much funding has Serina Therapeutics raised?
Serina Therapeutics has raised $10.0M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Apr 2025.
When did Serina Therapeutics last raise funding?
Serina Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Apr 2025.
Who founded Serina Therapeutics?
FundedIQ lists Michael Bentley (Founder) at Serina Therapeutics.
Where is Serina Therapeutics headquartered?
Serina Therapeutics is based in Huntsville, Alabama, United States.
How many employees does Serina Therapeutics have?
Serina Therapeutics is in the 11-50 employee band.
How does Serina Therapeutics' funding compare to other Biotechnology startups?
Serina Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Serina Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Serina Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.